Shri Rawatpura Sarkar Institute of Pharmacy, Kumhari, Durg, C.G, India; University Institute of Pharmacy, Pt. R. S. S. U, Raipur, C.G., India.
University Institute of Pharmacy, Pt. R. S. S. U, Raipur, C.G., India.
J Pharm Biomed Anal. 2018 Oct 25;160:31-37. doi: 10.1016/j.jpba.2018.07.025. Epub 2018 Jul 21.
Gefitinib is anticancer drug which is sparingly soluble in water. This limits its dissolution and bioavailability. Binary inclusion complex of gefitinib with Epi-β-CD was prepared by freeze-drying method. Stoichiometric ratio of 1:1 M was established by continuous variation (Job's) plot. The stability constant of complex as determined by phase solubility study was found to be 15,871.3 M. Complex was characterized by FTIR, DSC, DTA and dissolution study. Results revealed that in complex the drug no longer exist in crystalline state and is converted into amorphous form; which shows higher dissolution efficiency as compared to crystalline drug. The solubilizing efficiency for freeze dried complex was found to be 175.57 and the relative drug crystallinity degree was 87.91% as estimated by thermal analysis. Complexation led to decrease in surface tension; from 54.8 dynes/cm (pure gefitinib) to 40.3 dynes/cm (FD complex) due to adsorption phenomenon. The results obtained in this study confirmed that complexation of gefitinib with Epi-β-CD is a prominent approach and suitable tool for tailoring the issue related to its delivery and can be explored for development of an effective delivery system.
吉非替尼是一种抗癌药物,在水中的溶解度较低。这限制了它的溶解和生物利用度。通过冷冻干燥法制备了吉非替尼与 Epi-β-CD 的二元包合物。通过连续变化(Job's)图谱确定了 1:1 M 的化学计量比。通过相溶解度研究确定的配合物的稳定常数为 15,871.3 M。通过 FTIR、DSC、DTA 和溶解研究对配合物进行了表征。结果表明,在配合物中,药物不再以结晶状态存在,而是转化为无定形状态;与结晶药物相比,其显示出更高的溶解效率。通过热分析估计,冻干复合物的增溶效率为 175.57,相对药物结晶度为 87.91%。由于吸附现象,表面张力从 54.8 达因/厘米(纯吉非替尼)降低至 40.3 达因/厘米(FD 复合物)。本研究结果证实,吉非替尼与 Epi-β-CD 的络合是一种突出的方法,也是解决其传递问题的合适工具,可以探索开发有效的传递系统。